After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

As the father of an 18-year-old girl who died from a single OxyContin pill in 2006 and as a creditor in the Purdue Pharma bankruptcy proceeding, I must voice my strong disappointment in Illinois ...

“We’re on the frontier of Pharma 4.0 — autonomous experimentation, advanced robotics, big data, smart factories, AI and machine learning,” said Karen Plaut, Purdue’s executive vice president for ...

Trey Kaufman-Renn wasn't the Purdue player in first-half foul trouble, and it allowed him to play a starring role. Braden Smith showcased his generosity in a first half that was explosive.

That leads he – and his two brothers – to acquire Purdue Pharmaceuticals in the early 1950s. It had been going since the 1890s, and was a relatively small player, but Arthur & Co clearly had ...

WEST LAFAYETTE − Purdue basketball's defense got it through a tough road trip to the Pacific Northwest. The Boilermakers saw their seven-game winning streak end because the offense couldn't ...

a special speaker for songs like “Hail Purdue!” Our STEM-focused urban campus is preparing students for the jobs of tomorrow in areas such as AI, biomedical engineering, data science, cybersecurity ...

Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...

M, consensus $284.9M Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and ...

Biogen posted strong Q4 results, surpassing estimates, while forecasting a 2025 revenue decline. The company secured up to ...

Vanda Pharmaceuticals sees strong growth with Fanapt for bipolar I disorder, projects 2025 revenue up 6%-26%, and targets $1B by 2030.

Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...